MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00134-024-07349-z

Медицинская библиотека · Intensive care medicine · 2024

Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study.

Munshi Laveena, Dumas Guillaume, Rochwerg Bram, Shoukat Farah, Detsky Michael, Fergusson Dean A, Ferreyro Bruno L, Heffernan Paul, Herridge Margaret, Magder Sheldon, Minden Mark, Patel Rakesh, Qureshi Salman, Schimmer Aaron, Thyagu Santhosh, Wang Han Ting, Mehta Sangeeta

Наблюдательное исследованиеМногоцентровое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: Patients with hematologic malignancy (HM) commonly develop critical illness. Their long-term survival and functional outcomes have not been well described.

METHODS

We conducted a prospective, observational study of HM patients admitted to seven Canadian intensive care units (ICUs) (2018-2020). We followed survivors at 7 days, 6 months and 12 months following ICU discharge. The primary outcome was 12-month survival. We evaluated functional outcomes at 6 and 12 months using the functional independent measure (FIM) and short form (SF)-36 as well as variables associated with 12-month survival.

RESULTS

We enrolled 414 patients including 35% women. The median age was 61 (interquartile range, IQR: 52-69), median Sequential Organ Failure Assessment (SOFA) score was 9 (IQR: 6-12), and 22% had moderate-severe frailty (clinical frailty scale [CFS] ≥ 6). 51% had acute leukemia, 38% lymphoma/multiple myeloma, and 40% had received a hematopoietic stem cell transplant (HCT). The most common reasons for ICU admission were acute respiratory failure (50%) and sepsis (40%). Overall, 203 (49%) were alive 7 days post-ICU discharge (ICU survivors). Twelve-month survival of the entire cohort was 21% (43% across ICU survivors). The proportion of survivors with moderate-severe frailty was 42% (at 7 days), 14% (6 months), and 8% (12 months). Median FIM at 7 days was 80 (IQR: 50-109). Physical function, pain, social function, mental health, and emotional well-being were below age- and sex-matched population scores at 6 and 12 months. Frailty, allogeneic HCT, kidney injury, and cardiac complications during ICU were associated with lower 12- month survival.

CONCLUSIONS

49% of all HM patients were alive at 7 days post-ICU discharge, and 21% at 12 months. Survival varied based upon hematologic diagnosis and frailty status. Survivors had important functional disability and impairment in emotional, physical, and general well-being.

Для цитирования: Munshi Laveena, Dumas Guillaume, Rochwerg Bram, Shoukat Farah, Detsky Michael, Fergusson Dean A, Ferreyro Bruno L, Heffernan Paul, Herridge Margaret, Magder Sheldon, Minden Mark, Patel Rakesh, Qureshi Salman, Schimmer Aaron, Thyagu Santhosh, Wang Han Ting, Mehta Sangeeta. Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study.. Intensive care medicine. 2024. DOI: 10.1007/s00134-024-07349-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.